19 results
424B5
ANVS
Annovis Bio Inc
1 May 24
Prospectus supplement for primary offering
4:50pm
, including about adverse developments related to safety, effectiveness, accuracy and usability of their products, reputational concerns, reimbursement
424B5
ANVS
Annovis Bio Inc
18 Mar 24
Prospectus supplement for primary offering
10:00pm
adverse developments related to safety, effectiveness, accuracy and usability of their products, reputational concerns, reimbursement coverage, regulatory
424B5
ANVS
Annovis Bio Inc
18 Mar 24
Prospectus supplement for primary offering
8:51pm
adverse developments related to safety, effectiveness, accuracy and usability of their products, reputational concerns, reimbursement coverage, regulatory
424B5
ANVS
Annovis Bio Inc
1 Nov 23
Prospectus supplement for primary offering
12:24pm
direct competitors, including about adverse developments related to safety, effectiveness, accuracy and usability of their products, reputational concerns … confidence and raise reputational issues and may subject us to additional risks and uncertainties, including increased professional costs and the increased
424B5
94aq um433cp4s
30 Oct 23
Prospectus supplement for primary offering
5:27pm
10-K
tzoojn9 a3odgfo
25 Mar 20
Annual report
4:45pm
424B4
cvlr48 mrz8860
30 Jan 20
Prospectus supplement with pricing info
6:07am
S-1/A
h21y6 qh2w
8 Aug 19
IPO registration (amended)
5:23pm
S-1
fx4vyva7a1
2 Jul 19
IPO registration
9:15pm
DRS/A
s9chu yz9h0
24 May 19
Draft registration statement (amended)
12:00am
DRS
2xm7v6ggpu1v7zwmo
15 May 19
Draft registration statement
12:00am
- Prev
- 1
- Next